Research graph
References from Assessing Microstructural and Molecular Brain Changes in Early Cognitive Decline Using Multiparametric 3T Magnetic Resonance Imaging. Local targets link to admitted publications; unresolved targets remain external evidence.
Early detection of mild cognitive impairment (MCI) in primary care
10.14283/jpad.2020.21 · 2020 · External reference
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: A review and synthesis
10.1111/joim.13244 · 2021 · External reference
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
10.1212/wnl.0000000000009323 · 2020 · External reference
10.1001/jamaneurol.2025.3242
10.1001/jamaneurol.2025.3242 · External reference
Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup
10.1002/alz.13859 · 2024 · External reference
10.3390/neurolint18070139
10.3390/neurolint18070139 · External reference
10.7759/cureus.73353
10.7759/cureus.73353 · External reference
Importance of hypoglycemia episodes and glycemic variability in parkinsonian syndromes
10.5603/pjnns.109238 · 2025 · External reference
10.36922/an025270077
10.36922/an025270077 · External reference
Mapping scores onto stages: Mini-mental state examination and clinical dementia rating
10.1097/01.jgp.0000192478.82189.a8 · 2006 · External reference
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
10.2967/jnumed.124.268756 · 2025 · External reference
The clinical use of structural MRI in Alzheimer disease
10.1038/nrneurol.2009.215 · 2010 · External reference
Structural MRI changes detectable up to ten years before clinical Alzheimer’s disease
10.1016/j.neurobiolaging.2011.05.018 · 2012 · External reference
Magnetization transfer in MRI: A review
10.1002/nbm.683 · 2001 · External reference
Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain
10.1002/jmri.24768 · 2015 · External reference
10.1371/journal.pone.0049072
10.1371/journal.pone.0049072 · External reference
10.3389/fneur.2021.640239
10.3389/fneur.2021.640239 · External reference
10.1148/radiol.250513
10.1148/radiol.250513 · External reference
Neuroimaging and other biomarkers for Alzheimer’s disease: The changing landscape of early detection
10.1146/annurev-clinpsy-050212-185535 · 2013 · External reference
10.1177/25424823251394399
10.1177/25424823251394399 · External reference
Neuroimaging biomarkers for Alzheimer’s disease
10.1186/s13024-019-0325-5 · 2019 · External reference
A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)
10.1006/jmre.1999.1956 · 2000 · External reference
Chemical exchange saturation transfer imaging and spectroscopy
10.1016/j.pnmrs.2006.01.001 · 2006 · External reference
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides
10.1038/nm.2268 · 2011 · External reference
10.3390/ijms222111559
10.3390/ijms222111559 · External reference
10.1002/nbm.4731
10.1002/nbm.4731 · External reference
10.1002/nbm.4906
10.1002/nbm.4906 · External reference
Magnetic resonance imaging of glutamate
10.1038/nm.2615 · 2012 · External reference
10.3390/brainsci12010053
10.3390/brainsci12010053 · External reference
Amide proton transfer imaging of Alzheimer’s disease and Parkinson’s disease
10.1016/j.mrl.2022.10.002 · 2023 · External reference
10.1002/nbm.4780
10.1002/nbm.4780 · External reference
Chemical exchange saturation transfer MRI for neurodegenerative diseases: An update on clinical and preclinical studies
10.4103/nrr.nrr-d-24-01246 · 2026 · External reference
Soluble fibrillar oligomer levels are elevated in Alzheimer’s disease brain and correlate with cognitive dysfunction
10.1016/j.nbd.2009.05.024 · 2009 · External reference
The amyloid-beta oligomer hypothesis: Beginning of the third decade
10.3233/jad-179941 · 2018 · External reference
10.3390/neurolint18030048
10.3390/neurolint18030048 · External reference
Amide proton transfer magnetic resonance imaging of Alzheimer’s disease at 3.0 Tesla: A preliminary study
10.4103/0366-6999.151658 · 2015 · External reference
10.1016/j.nicl.2019.102153
10.1016/j.nicl.2019.102153 · External reference
10.3389/fneur.2021.707030
10.3389/fneur.2021.707030 · External reference
Robust Extrapolated Semi-Solid Magnetization Transfer Reference Fitting for Quantitative Amide Proton Transfer Imaging at 3 T: Application to Patients with Mild Cognitive Impairment and Mild Dementia
10.1002/mrm.70122 · 2026 · External reference
The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
10.1016/j.jalz.2011.03.008 · 2011 · External reference
The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
10.1016/j.jalz.2011.03.005 · 2011 · External reference
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments
10.1002/mrm.21873 · 2009 · External reference
Optimization of the ultrafast Look-Looker echo-plannar imaging T1 mapping sequence
10.1016/s0730-725x(98)00011-3 · 1998 · External reference
Quantitative Susceptibility Mapping Using Structural Feature Based Collaborative Reconstruction (SFCR) in the Human Brain
10.1109/tmi.2016.2544958 · 2016 · External reference
Multi-atlas tool for automated segmentation of brain gray matter nuclei and quantification of their magnetic susceptibility
10.1016/j.neuroimage.2019.02.016 · 2019 · External reference
Quantitative susceptibility mapping of brain iron and β-amyloid in MRI and PET relating to cognitive performance in cognitively normal older adults
10.1148/radiol.2020201603 · 2021 · External reference
APT-weighted MRI: Techniques, current neuro applications, and challenging issues
10.1002/jmri.26645 · 2019 · External reference
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
10.1016/j.neuroimage.2006.01.015 · 2006 · External reference
Neural correlates of Alzheimer’s disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients
10.1016/j.neuroimage.2009.05.037 · 2009 · External reference
Neuroanatomic changes and their association with cognitive decline in mild cognitive impairment: A meta-analysis
10.1007/s00429-011-0333-x · 2012 · External reference
Convergent and distinct neural structural and functional patterns of mild cognitive impairment: A multimodal meta-analysis
10.1093/cercor/bhad167 · 2023 · External reference
Cognitive tests to detect dementia: A systematic review and meta-analysis
10.1001/jamainternmed.2015.2152 · 2015 · External reference
The Clinical Dementia Rating (CDR) current version and scoring rules
10.1212/wnl.43.11.2412-a · 1993 · External reference
“Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician
10.1016/0022-3956(75)90026-6 · 1975 · External reference
The mini-mental state examination: A comprehensive review
10.1111/j.1532-5415.1992.tb01992.x · 1992 · External reference
10.1186/s12888-020-02910-8
10.1186/s12888-020-02910-8 · External reference
Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer’s disease
10.1016/s0022-510x(01)00553-6 · 2001 · External reference
10.21037/qims-24-1602
10.21037/qims-24-1602 · External reference
Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer’s disease
10.1016/j.jalz.2018.02.020 · 2018 · External reference
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease
10.1136/jnnp.71.4.441 · 2001 · External reference
Posterior cingulate cortex atrophy across the Alzheimer’s disease spectrum: A cross-sectional MRI study linking volumetrics to cognitive decline
10.1177/13872877251401612 · 2026 · External reference
Analysis of the posterior cingulate cortex with [18 F] FDG-PET and Naa/mI in mild cognitive impairment and Alzheimer’s disease: Correlations and differences between the two methods
10.1590/1980-57642015dn94000385 · 2015 · External reference
10.1016/j.neuroimage.2020.117433
10.1016/j.neuroimage.2020.117433 · External reference
Correlating quantitative susceptibility mapping with cognitive decline in Alzheimer’s disease
10.1093/brain/awx167 · 2017 · External reference
Increased iron deposition in putamen and substantia nigra correlates with cognitive function in cerebral small vessel disease: A quantitative susceptibility mapping study
10.1177/0271678x251377569 · 2026 · External reference
10.1016/j.ejrad.2020.109243
10.1016/j.ejrad.2020.109243 · External reference
10.1371/journal.pone.0076203
10.1371/journal.pone.0076203 · External reference
Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors
10.1002/mrm.29241 · 2022 · External reference
Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI
10.1002/mrm.20408 · 2005 · External reference
10.1002/nbm.3934
10.1002/nbm.3934 · External reference
Cognitive tests to detect dementia: A systematic review and meta-analysis
10.1001/jamainternmed.2015.2152 · ExternalCitation · doi-reference
10.1001/jamaneurol.2025.3242
10.1001/jamaneurol.2025.3242 · ExternalCitation · doi-reference
Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup
10.1002/alz.13859 · ExternalCitation · doi-reference
Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain
10.1002/jmri.24768 · ExternalCitation · doi-reference
APT-weighted MRI: Techniques, current neuro applications, and challenging issues
10.1002/jmri.26645 · ExternalCitation · doi-reference
Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI
10.1002/mrm.20408 · ExternalCitation · doi-reference
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments
10.1002/mrm.21873 · ExternalCitation · doi-reference
Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors
10.1002/mrm.29241 · ExternalCitation · doi-reference
Robust Extrapolated Semi-Solid Magnetization Transfer Reference Fitting for Quantitative Amide Proton Transfer Imaging at 3 T: Application to Patients with Mild Cognitive Impairment and Mild Dementia
10.1002/mrm.70122 · ExternalCitation · doi-reference
10.1002/nbm.3934
10.1002/nbm.3934 · ExternalCitation · doi-reference
10.1002/nbm.4731
10.1002/nbm.4731 · ExternalCitation · doi-reference
10.1002/nbm.4780
10.1002/nbm.4780 · ExternalCitation · doi-reference
10.1002/nbm.4906
10.1002/nbm.4906 · ExternalCitation · doi-reference
Magnetization transfer in MRI: A review
10.1002/nbm.683 · ExternalCitation · doi-reference
A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)
10.1006/jmre.1999.1956 · ExternalCitation · doi-reference
Neuroanatomic changes and their association with cognitive decline in mild cognitive impairment: A meta-analysis
10.1007/s00429-011-0333-x · ExternalCitation · doi-reference
“Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician
10.1016/0022-3956(75)90026-6 · ExternalCitation · doi-reference
10.1016/j.ejrad.2020.109243
10.1016/j.ejrad.2020.109243 · ExternalCitation · doi-reference
The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
10.1016/j.jalz.2011.03.005 · ExternalCitation · doi-reference
The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
10.1016/j.jalz.2011.03.008 · ExternalCitation · doi-reference
Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer’s disease
10.1016/j.jalz.2018.02.020 · ExternalCitation · doi-reference
Amide proton transfer imaging of Alzheimer’s disease and Parkinson’s disease
10.1016/j.mrl.2022.10.002 · ExternalCitation · doi-reference
Soluble fibrillar oligomer levels are elevated in Alzheimer’s disease brain and correlate with cognitive dysfunction
10.1016/j.nbd.2009.05.024 · ExternalCitation · doi-reference
Structural MRI changes detectable up to ten years before clinical Alzheimer’s disease
10.1016/j.neurobiolaging.2011.05.018 · ExternalCitation · doi-reference
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
10.1016/j.neuroimage.2006.01.015 · ExternalCitation · doi-reference
Neural correlates of Alzheimer’s disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients
10.1016/j.neuroimage.2009.05.037 · ExternalCitation · doi-reference
Multi-atlas tool for automated segmentation of brain gray matter nuclei and quantification of their magnetic susceptibility
10.1016/j.neuroimage.2019.02.016 · ExternalCitation · doi-reference
10.1016/j.neuroimage.2020.117433
10.1016/j.neuroimage.2020.117433 · ExternalCitation · doi-reference
10.1016/j.nicl.2019.102153
10.1016/j.nicl.2019.102153 · ExternalCitation · doi-reference
Chemical exchange saturation transfer imaging and spectroscopy
10.1016/j.pnmrs.2006.01.001 · ExternalCitation · doi-reference
Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer’s disease
10.1016/s0022-510x(01)00553-6 · ExternalCitation · doi-reference
Optimization of the ultrafast Look-Looker echo-plannar imaging T1 mapping sequence
10.1016/s0730-725x(98)00011-3 · ExternalCitation · doi-reference
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides
10.1038/nm.2268 · ExternalCitation · doi-reference
Magnetic resonance imaging of glutamate
10.1038/nm.2615 · ExternalCitation · doi-reference
The clinical use of structural MRI in Alzheimer disease
10.1038/nrneurol.2009.215 · ExternalCitation · doi-reference
Correlating quantitative susceptibility mapping with cognitive decline in Alzheimer’s disease
10.1093/brain/awx167 · ExternalCitation · doi-reference
Convergent and distinct neural structural and functional patterns of mild cognitive impairment: A multimodal meta-analysis
10.1093/cercor/bhad167 · ExternalCitation · doi-reference
Mapping scores onto stages: Mini-mental state examination and clinical dementia rating
10.1097/01.jgp.0000192478.82189.a8 · ExternalCitation · doi-reference
Quantitative Susceptibility Mapping Using Structural Feature Based Collaborative Reconstruction (SFCR) in the Human Brain
10.1109/tmi.2016.2544958 · ExternalCitation · doi-reference
The mini-mental state examination: A comprehensive review
10.1111/j.1532-5415.1992.tb01992.x · ExternalCitation · doi-reference
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: A review and synthesis
10.1111/joim.13244 · ExternalCitation · doi-reference
Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease
10.1136/jnnp.71.4.441 · ExternalCitation · doi-reference
Neuroimaging and other biomarkers for Alzheimer’s disease: The changing landscape of early detection
10.1146/annurev-clinpsy-050212-185535 · ExternalCitation · doi-reference
Quantitative susceptibility mapping of brain iron and β-amyloid in MRI and PET relating to cognitive performance in cognitively normal older adults
10.1148/radiol.2020201603 · ExternalCitation · doi-reference
10.1148/radiol.250513
10.1148/radiol.250513 · ExternalCitation · doi-reference
Increased iron deposition in putamen and substantia nigra correlates with cognitive function in cerebral small vessel disease: A quantitative susceptibility mapping study
10.1177/0271678x251377569 · ExternalCitation · doi-reference
Posterior cingulate cortex atrophy across the Alzheimer’s disease spectrum: A cross-sectional MRI study linking volumetrics to cognitive decline
10.1177/13872877251401612 · ExternalCitation · doi-reference
10.1177/25424823251394399
10.1177/25424823251394399 · ExternalCitation · doi-reference
10.1186/s12888-020-02910-8
10.1186/s12888-020-02910-8 · ExternalCitation · doi-reference
Neuroimaging biomarkers for Alzheimer’s disease
10.1186/s13024-019-0325-5 · ExternalCitation · doi-reference
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
10.1212/wnl.0000000000009323 · ExternalCitation · doi-reference
The Clinical Dementia Rating (CDR) current version and scoring rules
10.1212/wnl.43.11.2412-a · ExternalCitation · doi-reference
10.1371/journal.pone.0049072
10.1371/journal.pone.0049072 · ExternalCitation · doi-reference
10.1371/journal.pone.0076203
10.1371/journal.pone.0076203 · ExternalCitation · doi-reference
Early detection of mild cognitive impairment (MCI) in primary care
10.14283/jpad.2020.21 · ExternalCitation · doi-reference
Analysis of the posterior cingulate cortex with [18 F] FDG-PET and Naa/mI in mild cognitive impairment and Alzheimer’s disease: Correlations and differences between the two methods
10.1590/1980-57642015dn94000385 · ExternalCitation · doi-reference
10.21037/qims-24-1602
10.21037/qims-24-1602 · ExternalCitation · doi-reference
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
10.2967/jnumed.124.268756 · ExternalCitation · doi-reference
The amyloid-beta oligomer hypothesis: Beginning of the third decade
10.3233/jad-179941 · ExternalCitation · doi-reference
10.3389/fneur.2021.640239
10.3389/fneur.2021.640239 · ExternalCitation · doi-reference
10.3389/fneur.2021.707030
10.3389/fneur.2021.707030 · ExternalCitation · doi-reference
10.3390/brainsci12010053
10.3390/brainsci12010053 · ExternalCitation · doi-reference
10.3390/ijms222111559
10.3390/ijms222111559 · ExternalCitation · doi-reference
10.3390/neurolint18030048
10.3390/neurolint18030048 · ExternalCitation · doi-reference
10.3390/neurolint18070139
10.3390/neurolint18070139 · ExternalCitation · doi-reference
10.36922/an025270077
10.36922/an025270077 · ExternalCitation · doi-reference
Amide proton transfer magnetic resonance imaging of Alzheimer’s disease at 3.0 Tesla: A preliminary study
10.4103/0366-6999.151658 · ExternalCitation · doi-reference
Chemical exchange saturation transfer MRI for neurodegenerative diseases: An update on clinical and preclinical studies
10.4103/nrr.nrr-d-24-01246 · ExternalCitation · doi-reference
Importance of hypoglycemia episodes and glycemic variability in parkinsonian syndromes
10.5603/pjnns.109238 · ExternalCitation · doi-reference
10.7759/cureus.73353
10.7759/cureus.73353 · ExternalCitation · doi-reference
